Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 5, 2012

FDA Sanctions Roche’s HSV IgG Assays

  • FDA approved Roche’s Elecsys (HSV) types 1 and 2 IgG assays for use on the cobas™ platform. The assays are for use with sexually active individuals and pregnant women as an aid to the presumptive diagnosis of HSV1 or 2 infection. Roche says the HSV tests are the first automated assays available for integrated analyzer platforms, “which will enable labs to integrate efficient herpes testing into their existing workflow,” comments Randy Pritchard, vp of marketing at Roche Diagnostics.

    “The Elecsys HSV-2 IgG and HSV-3 IgG assays provide qualitititve determination of IgG antibodies in serum or plasma. The tests are used wtih Roche’s electrochemiluminescence technology, and are approved for use on a range of systems, including the Elecsys 2010, cobas e 411, cobas e 601, cobas e 602, and Modular Analytics E170 analyzers.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »